Plasmapheresis treatment in COVID-19–related autoimmune meningoencephalitis: Case series
•COVID-19 patients failing to regain consciousness require neurological assessment.•Brain imaging and lumbar puncture are required to determine CNS involvement.•Neurological involvement during COVID-19 infection can be immune mediated.•Plasmapheresis can be beneficial in COVID-19 patients with autoi...
Gespeichert in:
| Veröffentlicht in: | Brain, behavior, and immunity behavior, and immunity, 2020-07, Vol.87, p.155-158 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 158 |
|---|---|
| container_issue | |
| container_start_page | 155 |
| container_title | Brain, behavior, and immunity |
| container_volume | 87 |
| creator | Dogan, Lerzan Kaya, Dilaver Sarikaya, Tugce Zengin, Rehile Dincer, Alp Akinci, Ibrahim Ozkan Afsar, Nazire |
| description | •COVID-19 patients failing to regain consciousness require neurological assessment.•Brain imaging and lumbar puncture are required to determine CNS involvement.•Neurological involvement during COVID-19 infection can be immune mediated.•Plasmapheresis can be beneficial in COVID-19 patients with autoimmune encephalitis.
Severe SARS-CoV-2 (COVID-19) infection has the potential for a high mortality rate. In this paper, we report the results of plasmapheresis treatment in a series of severely ill patients with COVID-19–related autoimmune meningoencephalitis in the Intensive Care Unit (ICU). |
| doi_str_mv | 10.1016/j.bbi.2020.05.022 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7204750</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0889159120308035</els_id><sourcerecordid>2401102541</sourcerecordid><originalsourceid>FETCH-LOGICAL-c517t-bd32182206db3cb99e919856acf26c696830312899a27e89606f29269b001e443</originalsourceid><addsrcrecordid>eNp9kctu1DAUhi1ERYfCA7BBWbJJOMdOnBgkpGqgF6lSWQALNpbjnOl4lMtgO5XY9R14wz5JPZq2opuuvDjf-f3rfIy9QygQUH7cFG3rCg4cCqgK4PwFWyAoyDkK9ZItoGlUjpXCQ_Y6hA0AVAKbV-xQcNEoqeoF-_29N2Ew2zV5Ci5k0ZOJA40xc2O2vPx1_jVHdXvzz1NvInWZmePkhmEeKUuUG68mGi1t16Z30YVP2dIEygJ5R-ENO1iZPtDb-_eI_Tz59mN5ll9cnp4vjy9yW2Ed87YTHBvOQXatsK1SpFA1lTR2xaWVSjYCBPJGKcNrSrVBrrjiUrUASGUpjtiXfe52bgfqbCrvTa-33g3G_9WTcfrpZHRrfTVd65pDWVeQAj7cB_jpz0wh6sEFS31vRprmoHkJiMCrEhOKe9T6KQRPq8dvEPTOid7o5ETvnGiodHKSdt7_3-9x40FCAj7vAUpXunbkdbBud9bOebJRd5N7Jv4OER2dsA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2401102541</pqid></control><display><type>article</type><title>Plasmapheresis treatment in COVID-19–related autoimmune meningoencephalitis: Case series</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Dogan, Lerzan ; Kaya, Dilaver ; Sarikaya, Tugce ; Zengin, Rehile ; Dincer, Alp ; Akinci, Ibrahim Ozkan ; Afsar, Nazire</creator><creatorcontrib>Dogan, Lerzan ; Kaya, Dilaver ; Sarikaya, Tugce ; Zengin, Rehile ; Dincer, Alp ; Akinci, Ibrahim Ozkan ; Afsar, Nazire</creatorcontrib><description>•COVID-19 patients failing to regain consciousness require neurological assessment.•Brain imaging and lumbar puncture are required to determine CNS involvement.•Neurological involvement during COVID-19 infection can be immune mediated.•Plasmapheresis can be beneficial in COVID-19 patients with autoimmune encephalitis.
Severe SARS-CoV-2 (COVID-19) infection has the potential for a high mortality rate. In this paper, we report the results of plasmapheresis treatment in a series of severely ill patients with COVID-19–related autoimmune meningoencephalitis in the Intensive Care Unit (ICU).</description><identifier>ISSN: 0889-1591</identifier><identifier>EISSN: 1090-2139</identifier><identifier>DOI: 10.1016/j.bbi.2020.05.022</identifier><identifier>PMID: 32389697</identifier><language>eng</language><publisher>Netherlands: Elsevier Inc</publisher><subject>Autoimmune ; Autoimmune Diseases - therapy ; Betacoronavirus - pathogenicity ; Coronavirus Infections - complications ; Coronavirus Infections - therapy ; COVID-19 ; Encephalitis ; Female ; Humans ; Male ; Meningoencephalitis - complications ; Meningoencephalitis - therapy ; Middle Aged ; Pandemics ; Plasmapheresis ; Plasmapheresis - methods ; Pneumonia, Viral - complications ; Pneumonia, Viral - therapy ; SARS-CoV-2</subject><ispartof>Brain, behavior, and immunity, 2020-07, Vol.87, p.155-158</ispartof><rights>2020 Elsevier Inc.</rights><rights>Copyright © 2020 Elsevier Inc. All rights reserved.</rights><rights>2020 Elsevier Inc. All rights reserved. 2020 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c517t-bd32182206db3cb99e919856acf26c696830312899a27e89606f29269b001e443</citedby><cites>FETCH-LOGICAL-c517t-bd32182206db3cb99e919856acf26c696830312899a27e89606f29269b001e443</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.bbi.2020.05.022$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32389697$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dogan, Lerzan</creatorcontrib><creatorcontrib>Kaya, Dilaver</creatorcontrib><creatorcontrib>Sarikaya, Tugce</creatorcontrib><creatorcontrib>Zengin, Rehile</creatorcontrib><creatorcontrib>Dincer, Alp</creatorcontrib><creatorcontrib>Akinci, Ibrahim Ozkan</creatorcontrib><creatorcontrib>Afsar, Nazire</creatorcontrib><title>Plasmapheresis treatment in COVID-19–related autoimmune meningoencephalitis: Case series</title><title>Brain, behavior, and immunity</title><addtitle>Brain Behav Immun</addtitle><description>•COVID-19 patients failing to regain consciousness require neurological assessment.•Brain imaging and lumbar puncture are required to determine CNS involvement.•Neurological involvement during COVID-19 infection can be immune mediated.•Plasmapheresis can be beneficial in COVID-19 patients with autoimmune encephalitis.
Severe SARS-CoV-2 (COVID-19) infection has the potential for a high mortality rate. In this paper, we report the results of plasmapheresis treatment in a series of severely ill patients with COVID-19–related autoimmune meningoencephalitis in the Intensive Care Unit (ICU).</description><subject>Autoimmune</subject><subject>Autoimmune Diseases - therapy</subject><subject>Betacoronavirus - pathogenicity</subject><subject>Coronavirus Infections - complications</subject><subject>Coronavirus Infections - therapy</subject><subject>COVID-19</subject><subject>Encephalitis</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Meningoencephalitis - complications</subject><subject>Meningoencephalitis - therapy</subject><subject>Middle Aged</subject><subject>Pandemics</subject><subject>Plasmapheresis</subject><subject>Plasmapheresis - methods</subject><subject>Pneumonia, Viral - complications</subject><subject>Pneumonia, Viral - therapy</subject><subject>SARS-CoV-2</subject><issn>0889-1591</issn><issn>1090-2139</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kctu1DAUhi1ERYfCA7BBWbJJOMdOnBgkpGqgF6lSWQALNpbjnOl4lMtgO5XY9R14wz5JPZq2opuuvDjf-f3rfIy9QygQUH7cFG3rCg4cCqgK4PwFWyAoyDkK9ZItoGlUjpXCQ_Y6hA0AVAKbV-xQcNEoqeoF-_29N2Ew2zV5Ci5k0ZOJA40xc2O2vPx1_jVHdXvzz1NvInWZmePkhmEeKUuUG68mGi1t16Z30YVP2dIEygJ5R-ENO1iZPtDb-_eI_Tz59mN5ll9cnp4vjy9yW2Ed87YTHBvOQXatsK1SpFA1lTR2xaWVSjYCBPJGKcNrSrVBrrjiUrUASGUpjtiXfe52bgfqbCrvTa-33g3G_9WTcfrpZHRrfTVd65pDWVeQAj7cB_jpz0wh6sEFS31vRprmoHkJiMCrEhOKe9T6KQRPq8dvEPTOid7o5ETvnGiodHKSdt7_3-9x40FCAj7vAUpXunbkdbBud9bOebJRd5N7Jv4OER2dsA</recordid><startdate>20200701</startdate><enddate>20200701</enddate><creator>Dogan, Lerzan</creator><creator>Kaya, Dilaver</creator><creator>Sarikaya, Tugce</creator><creator>Zengin, Rehile</creator><creator>Dincer, Alp</creator><creator>Akinci, Ibrahim Ozkan</creator><creator>Afsar, Nazire</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20200701</creationdate><title>Plasmapheresis treatment in COVID-19–related autoimmune meningoencephalitis: Case series</title><author>Dogan, Lerzan ; Kaya, Dilaver ; Sarikaya, Tugce ; Zengin, Rehile ; Dincer, Alp ; Akinci, Ibrahim Ozkan ; Afsar, Nazire</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c517t-bd32182206db3cb99e919856acf26c696830312899a27e89606f29269b001e443</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Autoimmune</topic><topic>Autoimmune Diseases - therapy</topic><topic>Betacoronavirus - pathogenicity</topic><topic>Coronavirus Infections - complications</topic><topic>Coronavirus Infections - therapy</topic><topic>COVID-19</topic><topic>Encephalitis</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Meningoencephalitis - complications</topic><topic>Meningoencephalitis - therapy</topic><topic>Middle Aged</topic><topic>Pandemics</topic><topic>Plasmapheresis</topic><topic>Plasmapheresis - methods</topic><topic>Pneumonia, Viral - complications</topic><topic>Pneumonia, Viral - therapy</topic><topic>SARS-CoV-2</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dogan, Lerzan</creatorcontrib><creatorcontrib>Kaya, Dilaver</creatorcontrib><creatorcontrib>Sarikaya, Tugce</creatorcontrib><creatorcontrib>Zengin, Rehile</creatorcontrib><creatorcontrib>Dincer, Alp</creatorcontrib><creatorcontrib>Akinci, Ibrahim Ozkan</creatorcontrib><creatorcontrib>Afsar, Nazire</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Brain, behavior, and immunity</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dogan, Lerzan</au><au>Kaya, Dilaver</au><au>Sarikaya, Tugce</au><au>Zengin, Rehile</au><au>Dincer, Alp</au><au>Akinci, Ibrahim Ozkan</au><au>Afsar, Nazire</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Plasmapheresis treatment in COVID-19–related autoimmune meningoencephalitis: Case series</atitle><jtitle>Brain, behavior, and immunity</jtitle><addtitle>Brain Behav Immun</addtitle><date>2020-07-01</date><risdate>2020</risdate><volume>87</volume><spage>155</spage><epage>158</epage><pages>155-158</pages><issn>0889-1591</issn><eissn>1090-2139</eissn><abstract>•COVID-19 patients failing to regain consciousness require neurological assessment.•Brain imaging and lumbar puncture are required to determine CNS involvement.•Neurological involvement during COVID-19 infection can be immune mediated.•Plasmapheresis can be beneficial in COVID-19 patients with autoimmune encephalitis.
Severe SARS-CoV-2 (COVID-19) infection has the potential for a high mortality rate. In this paper, we report the results of plasmapheresis treatment in a series of severely ill patients with COVID-19–related autoimmune meningoencephalitis in the Intensive Care Unit (ICU).</abstract><cop>Netherlands</cop><pub>Elsevier Inc</pub><pmid>32389697</pmid><doi>10.1016/j.bbi.2020.05.022</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0889-1591 |
| ispartof | Brain, behavior, and immunity, 2020-07, Vol.87, p.155-158 |
| issn | 0889-1591 1090-2139 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7204750 |
| source | MEDLINE; Access via ScienceDirect (Elsevier) |
| subjects | Autoimmune Autoimmune Diseases - therapy Betacoronavirus - pathogenicity Coronavirus Infections - complications Coronavirus Infections - therapy COVID-19 Encephalitis Female Humans Male Meningoencephalitis - complications Meningoencephalitis - therapy Middle Aged Pandemics Plasmapheresis Plasmapheresis - methods Pneumonia, Viral - complications Pneumonia, Viral - therapy SARS-CoV-2 |
| title | Plasmapheresis treatment in COVID-19–related autoimmune meningoencephalitis: Case series |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T09%3A46%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Plasmapheresis%20treatment%20in%20COVID-19%E2%80%93related%20autoimmune%20meningoencephalitis:%20Case%20series&rft.jtitle=Brain,%20behavior,%20and%20immunity&rft.au=Dogan,%20Lerzan&rft.date=2020-07-01&rft.volume=87&rft.spage=155&rft.epage=158&rft.pages=155-158&rft.issn=0889-1591&rft.eissn=1090-2139&rft_id=info:doi/10.1016/j.bbi.2020.05.022&rft_dat=%3Cproquest_pubme%3E2401102541%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2401102541&rft_id=info:pmid/32389697&rft_els_id=S0889159120308035&rfr_iscdi=true |